Here's Why Vanda Pharmaceuticals Stock Soared on Thursday

Shares of Vanda Pharmaceuticals (NASDAQ: VNDA), a commercial-stage biotechnology company, jumped in response to the company's second-quarter earnings call. Investors happy about what management had to say drove the stock 26.8% higher on Thursday.

In the first quarter, Vanda reported a steep revenue drop, and investors were glad to see sales are back on track. In the second quarter net sales of Hetlioz, a treatment for non-24-hour sleep-wake disorder, came in 24% higher than during the first quarter. Vanda's schizophrenia drug, Fanapt, rose 13% compared to the first quarter.

Image source: Getty Images.

Continue reading

Quelle Fool.com